ArticleBrain topography2026
Bifocal Beta-frequency Transcranial Alternating Current Stimulation Enhances Somatosensory Spatial Discrimination.
Article in Brain topography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Somatosensory inputs are sequentially processed across multiple brain regions via cortico-cortical networks. Our recent magnetoencephalography (MEG) study identified specific beta-frequency cortico-cortical networks involved in tactile two-point discrimination (TPD), including those between primary somatosensory cortex (S1) and superior parietal lobule (SPL), and between S1 and angular gyrus (AG). These findings prompted us to investigate whether modifying these networks could influence TPD. We therefore examined the effects of bifocal beta-frequency transcranial alternating current stimulation (tACS) on TPD by specifically targeting the relevant networks. Thirty healthy adults participated in the study, which consisted of five sessions: an MRI scan, MEG recording, and three tACS sessions. Resting-state MEG and somatosensory-evoked magnetic fields were acquired using a 306-channel MEG system. During the intervention, 20-min tACS at each participant’s individual frequency was delivered to personalized targets—either the S1–SPL or S1–AG network—or administered as sham. TPD was automatically assessed at ten distances (0–5.0 mm) before, during, and after tACS. Bifocal beta-frequency tACS selectively modulated TPD thresholds at specific distances under both active conditions. Significant improvements were observed when tACS was applied to the S1–SPL network (3.0, 3.5, and 5.0 mm; all P < 0.049) and the S1–AG network (3.5 mm; all P < 0.046), whereas sham condition produced no significant effects. Electric field modeling confirmed that stimulation selectively targeted either the SPL or the AG, depending on the condition (all P < 0.02). Bifocal beta-frequency tACS targeting the S1–SPL or S1–AG network improves TPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.